Distribution Agreements in the Biotechnology Industry

84 Contracts & Agreements

Browse by Company

ADMA BIOLOGICS, INC. (1 contract)
Advaxis, Inc. (1)
Akebia Therapeutics, Inc. (1)
Alpha Healthcare Acquisition Corp. (3)
AMARIN CORP PLC (1)
Annovis Bio, Inc. (1)
Arcutis Biotherapeutics, Inc. (1)
Avita Therapeutics, Inc. (1)
AZIYO BIOLOGICS, INC. (1)
Biostage, Inc. (4)
Blue Water Vaccines Inc. (1)
BRAINSTORM CELL THERAPEUTICS INC. (4)
CAPRICOR THERAPEUTICS, INC. (3)
CASI Pharmaceuticals, Inc. (1)
Clovis Oncology, Inc. (2)
Coherus BioSciences, Inc. (1)
Conatus Pharmaceuticals Inc. (1)
CTI BIOPHARMA CORP (5)
CYTORI THERAPEUTICS, INC. (4)
Digital Development Partners, Inc. (2)
Gain Therapeutics, Inc. (1)
Immune Therapeutics, Inc. (5)
Isoray, Inc. (2)
LEAP THERAPEUTICS, INC. (1)
MARIZYME INC (2)
Medovex Corp. (1)
MiMedx Group, Inc. (1)
NAVIDEA BIOPHARMACEUTICALS, INC. (1)
NTN BUZZTIME INC (1)
Organicell Regenerative Medicine, Inc. (2)
Phio Pharmaceuticals Corp. (1)
PREDICTIVE TECHNOLOGY GROUP, INC. (1)
Prothena Corp plc (2)
SOLENO THERAPEUTICS INC (1)
United Therapeutics Corp (10)
USA EQUITIES CORP. (2)
Vericel Corp (11)

Recent Contracts

Distribution Agreement, dated December 11, 2024, by and between Annovis Bio, Inc. and Oppenheimer & Co. Inc (Annovis Bio, Inc., Filed With SEC on December 11, 2024)
Term Sheet for Distribution of Deramiocel (CAP-1002) in Europe, by and between the Company and Nippon Shinyaku Co., Ltd (CAPRICOR THERAPEUTICS, INC., Filed With SEC on November 14, 2024)
Eleventh Amendment to the Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated July 31, 2024 (Vericel Corp, Filed With SEC on November 7, 2024)
Exclusive Distribution Agreement, between Harvard Apparatus Regenerative Technology, Inc. and Health Regen, Inc., dated October 31, 2024 (Biostage, Inc., Filed With SEC on November 6, 2024)
Distribution Agreement, dated September 6, 2024, by and between Gain Therapeutics, Inc. and Oppenheimer & Co. Inc (Gain Therapeutics, Inc., Filed With SEC on September 6, 2024)
Tenth Amendment to the Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated July 1, 2024 (Vericel Corp, Filed With SEC on August 1, 2024)
Exclusive Distribution Agreement between AVITA Medical Americas, LLC and Stedical Scientific, Inc, dated January 10, 2024 (Avita Therapeutics, Inc., Filed With SEC on May 13, 2024)
Amendment No. 1 dated April 2, 2024 to the Distribution Agreement dated August 9, 2024 by and among Brainstorm Cell Therapeutics Inc., Leerink Partners LLC and Raymond James &... (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on April 2, 2024)
Exclusive Distribution Agreement, dated September 20, 2023, between the Company and Cardinal Health 105, LLC (Blue Water Vaccines Inc., Filed With SEC on November 17, 2023)
Distribution Agreement by and between Aziyo Biologics, Inc. and LeMaitre Vascular, Inc (AZIYO BIOLOGICS, INC., Filed With SEC on August 14, 2023)
Japan Commercialization and Distribution Agreement, dated as of February 10, 2023, by and among Capricor Therapeutics, Inc., Capricor, Inc. and Nippon Shinyaku Co. Ltd (CAPRICOR THERAPEUTICS, INC., Filed With SEC on March 17, 2023)
Distribution Agreement, dated September 9, 2022, by and among Plus Therapeutics, Inc. and Canaccord Genuity LLC (CYTORI THERAPEUTICS, INC., Filed With SEC on September 9, 2022)
Eighth Amendment to the Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated May 15, 2022 (Vericel Corp, Filed With SEC on August 3, 2022)
Commercialization and Distribution Agreement, dated as of January 25, 2022, by and among Capricor Therapeutics, Inc., Capricor, Inc. and Nippon Shinyaku Co. Ltd (CAPRICOR THERAPEUTICS, INC., Filed With SEC on March 11, 2022)
Distribution Agreement, dated January 14, 2022, by and among Plus Therapeutics, Inc. and Canaccord Genuity LLC (CYTORI THERAPEUTICS, INC., Filed With SEC on January 14, 2022)
Distribution Agreement, dated December 23 2021, by and among the Company, Piper Sandler & Co., Stifel, Nicolaus & Company, Incorporated, Cantor Fitzgerald & Co., RBC Capital... (Prothena Corp plc, Filed With SEC on December 23, 2021)
Distribution Agreement, dated September 3, 2021, by and between ADMA Biologics, Inc. and Raymond James & Associates, Inc (ADMA BIOLOGICS, INC., Filed With SEC on September 3, 2021)
Distribution Agreement, dated August 16, 2021, by and among Clovis Oncology, Inc., J.P. Morgan Securities LLC and BofA Securities, Inc (Clovis Oncology, Inc., Filed With SEC on August 16, 2021)
Distribution Agreement, dated May 28, 2021, by and among the Company, Piper Sandler & Co., Stifel, Nicolaus & Company, Incorporated, Cantor Fitzgerald & Co., RBC Capital Markets,... (Prothena Corp plc, Filed With SEC on May 28, 2021)
Distribution Agreement, dated May 17, 2021, by and among Clovis Oncology, Inc., J.P. Morgan Securities LLC and BofA Securities, Inc (Clovis Oncology, Inc., Filed With SEC on May 17, 2021)
Exclusive Distribution Agreement, dated February 8, 2021, by and between the Registrant and Cardinal Health 105, Inc (Arcutis Biotherapeutics, Inc., Filed With SEC on May 6, 2021)
Amended and Restated Royalty Agreement and Distribution Agreement, dated as of March 22, 2021 (NTN BUZZTIME INC, Filed With SEC on March 31, 2021)
Amendment No. 1 to Exclusive Distribution Agreement by and between USA Equites Corp. and MedScience Research Group, Inc., dated March 26, 2021. Portions of the Distribution... (USA EQUITIES CORP., Filed With SEC on March 26, 2021)
Second Amendment to Distribution Agreement, effective as of February 16, 2021, by and between Fresenius Medical Care Holdings, Inc. and Humacyte, Inc (Alpha Healthcare Acquisition Corp., Filed With SEC on March 23, 2021)
First Amendment to Distribution Agreement, dated October 2, 2019, by and between Fresenius Medical Care Holdings, Inc. and Humacyte, Inc (Alpha Healthcare Acquisition Corp., Filed With SEC on March 23, 2021)
Distribution Agreement, dated June 25, 2018, by and between Fresenius Medical Care Holdings, Inc. and Humacyte, Inc (Alpha Healthcare Acquisition Corp., Filed With SEC on March 23, 2021)
Exclusive Distribution Agreement by and between USA Equites Corp. and MedScience Research Group, Inc., dated October 23, 2020. Portions of the Distribution Agreement containing... (USA EQUITIES CORP., Filed With SEC on October 26, 2020)
Distribution Agreement, dated October 23, 2020, by and among Plus Therapeutics, Inc. and Canaccord Genuity LLC (CYTORI THERAPEUTICS, INC., Filed With SEC on October 23, 2020)
Amended and Restated Distribution Agreement, dated September 25, 2020, by and among Brainstorm Cell Therapeutics Inc., SVB Leerink LLC and Raymond James & Associates, Inc (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on September 25, 2020)
LICENSING and DISTRIBUTION AGREEMENT (MARIZYME INC, Filed With SEC on June 5, 2020)
Exclusive Distribution Services Agreement, dated April 1, 2020, by and between Predictive Laboratories, Inc. and Wellgistics, LLC. (Portions of this exhibit have been omitted in... (PREDICTIVE TECHNOLOGY GROUP, INC., Filed With SEC on April 7, 2020)
Distribution Agreement between Black Bird Potentials Inc. (a Wyoming corporation) and Gorilla Mitts, LLC (Digital Development Partners, Inc., Filed With SEC on April 3, 2020)
Distribution Agreement between Black Bird Potentials Inc. (a Wyoming corporation) and CBD INC Limited Liability Partnership (Digital Development Partners, Inc., Filed With SEC on April 3, 2020)
Distribution Agreement, dated March 6, 2020, by and between Brainstorm Cell Therapeutics Inc. and Raymond James & Associates, Inc (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on March 6, 2020)
LICENSING and DISTRIBUTION AGREEMENT (MARIZYME INC, Filed With SEC on November 13, 2019)
Sixth Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated April 18, 2019 (Vericel Corp, Filed With SEC on August 6, 2019)
Distribution Agreement, dated June 11, 2019, by and between Brainstorm Cell Therapeutics Inc. and Raymond James & Associates, Inc (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on June 11, 2019)
Exclusive Distribution Agreement, effective as of March 5, 2019, by and among CASI Pharmaceuticals, Inc., China Resources Guokang Pharmaceuticals Co., Ltd. and CASI (Beijing)... (CASI Pharmaceuticals, Inc., Filed With SEC on May 15, 2019)
Exclusive Distribution Agreement between Keryx Biopharmaceuticals, Inc. and Cardinal Health 105, Inc., dated October 16, 2014 and Amendment to Exclusive Distribution Agreement... (Akebia Therapeutics, Inc., Filed With SEC on March 26, 2019)
Fifth Amendment to Distribution Agreement between Orsini Pharmaceutical Services, Inc. and theCompany, dated October 18, 2018 (Vericel Corp, Filed With SEC on November 6, 2018)